SlideShare ist ein Scribd-Unternehmen logo
1 von 103
HSS4303B – Introduction to Epidemiology Jan 14, 2010 – Measures of Morbidity & Mortality Epidemiologists: “Are they smart and good looking, or good looking and smart?"  Discuss.
From last class.... ,[object Object],[object Object]
From last class ,[object Object],[object Object],[object Object]
So What Has The Lit Review Revealed?
Dietary fat and breast cancer (1) ,[object Object],[object Object],[object Object],[object Object]
Aside: Ecological Fallacy ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dietary fat and breast cancer (2) ,[object Object],[object Object],[object Object],[object Object],[object Object]
So? Do You Have Enough Info To Inform The Patient?
Use A Systematic Review ,[object Object],[object Object]
Want To See Some Examples? ,[object Object],[object Object]
Systematic review (1) ,[object Object],[object Object],[object Object],[object Object],Meta-analysis Um… meta-analysis?
Terminology ,[object Object],Systematic reviews do not  have  to have a meta-analysis - there are times when it is not appropriate or possible A meta-analysis is also possible without doing a systematic review - you could just find a few studies and calculate a result, with no attempt to be systematic about how the particular studies were chosen.
More About Meta-Analysis ,[object Object],[object Object],[object Object]
The “Forest Plot” ,[object Object],[object Object],[object Object]
 
Systematic review (2) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Systematic reviews ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Meta-analysis of dietary fat intake and risk of breast cancer ,[object Object],[object Object],[object Object],[object Object]
Meta-analysis of five hypothetical epidemiologic studies (A–E) of the relationship between reduced dietary fat intake and the risk of developing breast cancer.
Terms Associated with Meta-Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
More on Q ,[object Object],[object Object],[object Object]
Interpreting Q ,[object Object],[object Object],[object Object]
More on I 2 ,[object Object],[object Object],[object Object],[object Object]
Why Do We Compute Q and I 2 ? ,[object Object],[object Object],[object Object],[object Object]
Heterogeneity statistics for examples of meta-analyses from the literature. Meta-analyses were conducted using either  meta  or  metan  in STATA 15 df=degrees of freedom. Heterogeneity test Topic Outcome/ analysis Effect measure No of studies Q df P I 2 (95% uncertainty interval) * Tamoxifen for breast cancer 16 Mortality  Peto odds ratio  55  55.9  54  0.40  3 (0 to 28)  Streptokinase after myocardial infarction 17 Mortality  Odds ratio  33  39.5  32  0.17  19 (0 to 48)  Selective serotonin reuptake inhibitors for depression 13 Drop-out  Odds ratio  135  179.9  134  0.005  26 (7 to 40)  Magnesium for acute myocardial infarction 18 Death  Odds ratio  16  40.2  15  0.0004  63 (30 to 78)  Magnetic fields and leukaemia 19 All studies  Odds ratio  6  15.9  5  0.007  69 (26 to 87)  Amantadine 11 Prevention of influenza  Odds ratio  8  12.44  7  0.09  44 (0 to 75)
Meta-analyses of six case-control studies relating residential exposure to electromagnetic fields to childhood leukaemia. Summary odds ratio calculated by random effects method Eg.
Okay, on to today’s topic...
Smoking more than one pack of cigarettes a day increases the risk of cardiovascular disease by 70%-80%, and smoking more than two packs per day increases the risk by 200%. Passive smoke increases the risk by 30%.  - Basic Res Cardiol 2000 (Suppl I); 95:152-158 normal rate of miscarriage of pregnancy is 2 to 3%, and amniocentesis increases that risk by an additional 1/2 to 1%. - ds-health.com A 1-month delay in treatment for an early-stage primary breast cancer with a 130-day doubling time increases the risk of axillary lymph node involvement by 0.9% - Obstet Gynecol. 1996 Mar;87(3):414-8.
A measure of the occurrence of new cases of the disease of interest in a population The probability of obtaining an outcome, given the presence or change in status of an exposure ?
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
In 1022 cancer patients with fever and granulocytopenia, 530 patients developed clinically or microbiologically documented bacterial infections What is the risk of infection in granulocytopenic febrile cancer patients? 530/1022 =  0.518  = 51.8%
Remember This?
A recent study found that 30% of women who date online have had sex on the first date with gentlemen they've met online. Moreover, the study found that 77% of these women had had  unprotected  sex in those encounters.  -w ww.onlinedatingmagazine.com/news2007/womenonlinedatersrisky.html "When you have unprotected sex with people you are meeting online, you are playing russian roullette [sic] with your health. It's not a matter of 'if' you'll get a sexually transmitted disease, but rather 'when' and 'how many'.” -’STI expert’ responding to the results of the study
How would you go about calculating the  actual  risk of a heterosexual Canadian woman contracting an STI fro unprotected sex with a random Canadian man? What would you need to know? ,[object Object],[object Object]
Canada’s STI Surveillance Report: www.phac-aspc.gc.ca The current prevalence is164 cases per 100,000 population, or about 0.16% of the total population, assuming a conservatively estimated base population of 35 million But is the right prevalence statistic to use?
The age-specific chlamydia burden among Canadian men aged 25+ is 9374 cases. Canadian adult male population of about 20 million Risk of Canadian male having Chlamydia = 9374/20000000 = 0.00047 = 0.05% Is that the end of the story?
Transmission So far we've been talking about the chances of being  exposed  to an STI. What about actually contracting one? The transmission rate of Chlamydia is between 30% and 40%. In other words, only 30-40% of sexual encounters with an infected person will result in the disease being transmitted. 30% of 0.05% = 0.015% 40% of 0.05% = 0.020%
So, assuming the more conservative estimate (0.02% chance of both exposure and transmission), a Canadian woman would have to sleep with 5000 men to get anything resembling the “guarantee” of an STI that the “expert” suggested. What is wrong with this analysis?
 
 
Two Terms: ,[object Object],[object Object]
Two Terms: ,[object Object],[object Object],[object Object],[object Object],[object Object]
Measurements of Morbidity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Incidence ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Incidence ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
However ,[object Object],[object Object],[object Object]
Cumulative incidence vs Incidence Density ,[object Object],[object Object],[object Object],[object Object]
Incidence Density ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
http://www.phac-aspc.gc.ca/publicat/haest-tesvs/appendix-eng.php Another Way of Looking at It
http://www.phac-aspc.gc.ca/publicat/haest-tesvs/appendix-eng.php
http://www.phac-aspc.gc.ca/publicat/haest-tesvs/appendix-eng.php
 
Incidence ,[object Object],IR = 28/1000  = 28 cases per 1000 population   or = 2.8% Is this cumulative incidence or incidence density?
Incidence ,[object Object],IR = A/PT = 28/(1000x2) = 14 per 1000 person-years Is this cumulative incidence or incidence density? This is an easy example of density, since all the residents of Raywatville were observed for the same duration
Incidence density =   A _______   P  x  T =   A cases ______________ P persons x  T time =   28 cases ---------------------- 1000 persons x 2 years = 14  cases   ----------   person-years
Example  (p.21) ,[object Object],[object Object],[object Object],4.7 cases / 1000 patient-days Is this cumulative incidence or incidence density? 596 new cases divided by 127,859 patient-days, all multiplied by 1000
Another Example ,[object Object],[object Object],[object Object],[object Object],19,185,836 women x 5 years = 95,929,180 woman-years.  Second, what is the incidence rate for leukemia for this period for this population? IR=A/PT = 2957/95929180 = 0.03 cases per 1000 woman-years
Incidence rates Six patients were observed for 8 years.  During that time, 2 were diagnosed with dumbass disease How would you go about computing the incidence rate of dumbass disease over this 8 year period? Cumulative incidence or incidence density?
Incidence rates Patient Years at risk A B C D E F
Incidence rates Patient Years at risk A B C D E F 2 2 3 7 2 6
Incidence rates Incidence rate = A / PT A = 2 PT = 2+2+3+7+2+6 = 22 2 / 22 = 0.09 cases / person-year 9 cases / 100 person-years
Acute hepatitis incidence in Canada
Incidence rate calculation for a big population ,[object Object],[object Object],[object Object],[object Object]
Identifying new cases: step 1
Identifying new cases: step 2
Why is incidence important?
Expected and observed new cases
Prevalence http://www.worldmapper.org/display.php?selected=227   HIV
Prevalence Rate ,[object Object],[object Object],[object Object],[object Object]
But you can also present it as a percent
Or… PR =   A    ----------------- A + B A = number of cases of the disease B = number of people in the population who do  not  have the disease, but who are at risk for getting it. Therefore A+B = total number of people in the population
Example: Obesity in the USA (from CDC.gov)
“ Point” Prevalence ,[object Object],[object Object],[object Object],[object Object],[object Object]
“ Period” Prevalence ,[object Object],[object Object],[object Object],[object Object]
23% of this class is left handed In 2008, 28% of Americans were clinically obese Point prevalence Period prevalence Interview Question Type of Measure "Do you currently have asthma?" Point prevalence "Have you had asthma during the last  (n)  years?" Period prevalence "Have you ever had asthma?" Cumulative incidence
Consider an old film camera… A single click of the camera produces an image.  The total photons on the film, or dots on the image, constitute the  point prevalence . If you leave the shutter open for a few seconds, and point the camera to an unmoving object, then many photons accumulate on the film.  This is  period prevalence . If you use a movie camera and analyze individual frames, then the number of  new  events in each frame constitute the  incidence rate  for that frame.
Incidence and prevalence
Relationship between incidence and prevalence ,[object Object],[object Object],[object Object],[object Object],[object Object]
Point prevalence for positive x-rays Table 3-7. Hypothetical Example of Chest X-Ray Screening: II. Point Prevalence Screened Population No. with Positive X-Ray Point Prevalence per 1,000 Population 1,000 Hitown 100 100 1,000 Lotown 60 60 Table 3-8. Hypothetical Example of Chest X-Ray Screening: III. Prevalence, Incidence, and Duration Screened Population Point Prevalence per 1,000 Incidence (Occurrences/yr) Duration (yrs) Hitown 100 4 25 Lotown 60 20 3   Prevalence = Incidence × Duration  
Breast cancer incidence
What are the pitfalls of finding Inc/Prev Data? ,[object Object]
 
Incidence/Prevalence Homework ,[object Object]
Mortality ,[object Object]
Mortality Rates ,[object Object],[object Object]
The  crude death rate , the total number of deaths per year per 1000 people. The crude death rate for the whole world is currently about 8.24 per 1000 per year (according to the current CIA World Factbook.) The  perinatal mortality rate , the sum of neonatal deaths and fetal deaths (stillbirths) per 1000 births. (WHO -> 22 weeks pregnancy until 7 days of life) The  maternal mortality rate , the number of maternal deaths due to childbearing per 100,000 live births. The  infant mortality rate , the number of deaths of children less than 1 year old per 1000 live births. The  child mortality rate , the number of deaths of children less than 5 years old per 1000 live births. The  standardised mortality rate  (SMR)- This represents a proportional comparison to the numbers of deaths that would have been expected if the population had been of a standard composition in terms of age, gender, etc. The  age-specific mortality rate  (ASMR) - This refers to the total number of deaths per year per 1000 people of a given age (e.g. age 62 last birthday).
Infant, neonatal, and postneonatal mortality rates: United States, 1940-2005 (Wikipedia)
 
 
 
Google public data.
 
Selected leading causes of death, by sex in Canada    1997   Number % Total Males Females     Rate 1   All causes 215,669 100.0 658.7 844.0 521.6 Cancers 58,703 27.2 181.5 229.7 148.5 Diseases of the heart  57,417 26.6 173.0 230.8 129.7 Cerebrovascular diseases  16,051 7.4 47.8 52.8 43.9 Chronic obstructive pulmonary diseases and allied conditions  9,618 4.5 29.0 44.5 20.1 Unintentional injuries 8,626 4.0 27.6 37.8 17.9 Pneumonia and influenza  8,032 3.7 23.7 31.5 19.2 Diabetes mellitus  5,699 2.6 17.4 20.6 14.8 Hereditary and degenerative diseases of the central nervous system 5,049 2.3 15.0 16.7 13.9 Diseases of arteries, arterioles and capillaries 4,767 2.2 14.3 19.5 10.6 Psychoses 4,645 2.2 13.6 13.3 13.4 Suicide  3,681 1.7 12.0 19.5 4.9
Where Do We Get These Data? ,[object Object],[object Object],[object Object]
How Do We Get This Data? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Active or Passive? ,[object Object],[object Object],Active Passive Why do we need surveillance?
Example: crude data from the Canadian Injuries Surveillance System: Leading causes of death due to injury, 2004 -passive system based on automatic processing of death certificates and hospital charts
Example: Canadian Notifiable Disease Surveillance Report, June 2007 (Ontario is blank because no data was available from Ontario in June/2007) Active system requiring doctors to call the government when certain illness arise
Last Thing: Ecological Studies ,[object Object]
Ecological Study ,[object Object],[object Object],[object Object],[object Object],[object Object]
Ecological Study ,[object Object],[object Object],[object Object]
Ecological Studies ,[object Object],[object Object],[object Object],[object Object],[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

Lec4 morbidity(revised07)
Lec4 morbidity(revised07)Lec4 morbidity(revised07)
Lec4 morbidity(revised07)Abeer Esmail
 
Mortality indicators
Mortality indicatorsMortality indicators
Mortality indicatorsSreeharsha P
 
Measurement of morbidity
Measurement of morbidityMeasurement of morbidity
Measurement of morbiditydrjagannath
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityADIL .
 
Occurrence of disease morbidity
Occurrence of disease morbidityOccurrence of disease morbidity
Occurrence of disease morbidityMmedsc Hahm
 
Mortality and mobidity indicators
Mortality and mobidity indicatorsMortality and mobidity indicators
Mortality and mobidity indicatorsPriyamadhaba Behera
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentationDrsadhana Meena
 
presentation on mortality and morbidity rate.
presentation on mortality and morbidity rate.presentation on mortality and morbidity rate.
presentation on mortality and morbidity rate.SonaliKatoch5
 
Mortality dr.wah
Mortality dr.wahMortality dr.wah
Mortality dr.wahMmedsc Hahm
 
Epidemiology lecture 4 death rates
Epidemiology lecture 4 death ratesEpidemiology lecture 4 death rates
Epidemiology lecture 4 death ratesINAAMUL HAQ
 
Mortality measurement
Mortality measurementMortality measurement
Mortality measurementAbino David
 
Understanding Malaysian Health Statistics
Understanding Malaysian Health StatisticsUnderstanding Malaysian Health Statistics
Understanding Malaysian Health StatisticsAzmi Mohd Tamil
 
Measurements in epidemiology
Measurements in epidemiologyMeasurements in epidemiology
Measurements in epidemiologyRizwan S A
 
Crude Rate, Age Adjusted Rate, Age Specific Rates in Cancer
Crude Rate, Age Adjusted Rate, Age Specific Rates in CancerCrude Rate, Age Adjusted Rate, Age Specific Rates in Cancer
Crude Rate, Age Adjusted Rate, Age Specific Rates in CancerRamnath Takiar
 
Methodology of Morbidity study
Methodology of Morbidity studyMethodology of Morbidity study
Methodology of Morbidity studyEneutron
 
Measurements of Mortality pwp
Measurements of Mortality pwpMeasurements of Mortality pwp
Measurements of Mortality pwpTom McLean
 
Measurement in epidemiology
Measurement in epidemiologyMeasurement in epidemiology
Measurement in epidemiologySuraj Dhara
 

Was ist angesagt? (20)

Lec4 morbidity(revised07)
Lec4 morbidity(revised07)Lec4 morbidity(revised07)
Lec4 morbidity(revised07)
 
Mortality indicators
Mortality indicatorsMortality indicators
Mortality indicators
 
Measurement of morbidity
Measurement of morbidityMeasurement of morbidity
Measurement of morbidity
 
Measuring Disease Frequency
Measuring Disease FrequencyMeasuring Disease Frequency
Measuring Disease Frequency
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
 
Occurrence of disease morbidity
Occurrence of disease morbidityOccurrence of disease morbidity
Occurrence of disease morbidity
 
Mortality and mobidity indicators
Mortality and mobidity indicatorsMortality and mobidity indicators
Mortality and mobidity indicators
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentation
 
16
1616
16
 
presentation on mortality and morbidity rate.
presentation on mortality and morbidity rate.presentation on mortality and morbidity rate.
presentation on mortality and morbidity rate.
 
Mortality dr.wah
Mortality dr.wahMortality dr.wah
Mortality dr.wah
 
Epidemiology lecture 4 death rates
Epidemiology lecture 4 death ratesEpidemiology lecture 4 death rates
Epidemiology lecture 4 death rates
 
Mortality measurement
Mortality measurementMortality measurement
Mortality measurement
 
Understanding Malaysian Health Statistics
Understanding Malaysian Health StatisticsUnderstanding Malaysian Health Statistics
Understanding Malaysian Health Statistics
 
Epidemilogy
EpidemilogyEpidemilogy
Epidemilogy
 
Measurements in epidemiology
Measurements in epidemiologyMeasurements in epidemiology
Measurements in epidemiology
 
Crude Rate, Age Adjusted Rate, Age Specific Rates in Cancer
Crude Rate, Age Adjusted Rate, Age Specific Rates in CancerCrude Rate, Age Adjusted Rate, Age Specific Rates in Cancer
Crude Rate, Age Adjusted Rate, Age Specific Rates in Cancer
 
Methodology of Morbidity study
Methodology of Morbidity studyMethodology of Morbidity study
Methodology of Morbidity study
 
Measurements of Mortality pwp
Measurements of Mortality pwpMeasurements of Mortality pwp
Measurements of Mortality pwp
 
Measurement in epidemiology
Measurement in epidemiologyMeasurement in epidemiology
Measurement in epidemiology
 

Andere mochten auch

Cambios En El Error En Medicina
Cambios En El Error En MedicinaCambios En El Error En Medicina
Cambios En El Error En Medicinarahterrazas
 
Error En Medicina
Error En MedicinaError En Medicina
Error En Medicinarahterrazas
 
Error Humano, Mala Praxis
Error Humano, Mala PraxisError Humano, Mala Praxis
Error Humano, Mala Praxisguestc912898
 
Error en Medicina - XII Congreso Médico del Norte
Error en Medicina - XII Congreso Médico del Norte Error en Medicina - XII Congreso Médico del Norte
Error en Medicina - XII Congreso Médico del Norte Frank Cajina Gómez
 
Negligencia medica
Negligencia medicaNegligencia medica
Negligencia medicaDanae Torres
 
Los 10 errores médicos y la lesión al
Los 10 errores médicos y la lesión alLos 10 errores médicos y la lesión al
Los 10 errores médicos y la lesión alJose Pinto Llerena
 

Andere mochten auch (10)

Cambios En El Error En Medicina
Cambios En El Error En MedicinaCambios En El Error En Medicina
Cambios En El Error En Medicina
 
Error En Medicina
Error En MedicinaError En Medicina
Error En Medicina
 
Error Humano, Mala Praxis
Error Humano, Mala PraxisError Humano, Mala Praxis
Error Humano, Mala Praxis
 
Malapraxis modificado
Malapraxis modificadoMalapraxis modificado
Malapraxis modificado
 
Error en Medicina - XII Congreso Médico del Norte
Error en Medicina - XII Congreso Médico del Norte Error en Medicina - XII Congreso Médico del Norte
Error en Medicina - XII Congreso Médico del Norte
 
ENFERMEDAD IATROGENICA
ENFERMEDAD IATROGENICAENFERMEDAD IATROGENICA
ENFERMEDAD IATROGENICA
 
Negligencia medica
Negligencia medicaNegligencia medica
Negligencia medica
 
Los 10 errores médicos y la lesión al
Los 10 errores médicos y la lesión alLos 10 errores médicos y la lesión al
Los 10 errores médicos y la lesión al
 
Negligencia Medica
Negligencia MedicaNegligencia Medica
Negligencia Medica
 
Error en Medicina - 2008
Error en Medicina - 2008Error en Medicina - 2008
Error en Medicina - 2008
 

Ähnlich wie Hss4303b mortality and morbidity

Research methodology 101
Research methodology 101Research methodology 101
Research methodology 101Hesham Gaber
 
Lemeshow samplesize
Lemeshow samplesizeLemeshow samplesize
Lemeshow samplesize1joanenab
 
Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011NES
 
Case control surveillance
Case control surveillanceCase control surveillance
Case control surveillanceManiz Joshi
 
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptxDr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptxPriyankaSharma89719
 
Medpage guide-to-biostatistics
Medpage guide-to-biostatisticsMedpage guide-to-biostatistics
Medpage guide-to-biostatisticsElsa von Licy
 
Parmetric and non parametric statistical test in clinical trails
Parmetric and non parametric statistical test in clinical trailsParmetric and non parametric statistical test in clinical trails
Parmetric and non parametric statistical test in clinical trailsVinod Pagidipalli
 
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docx
Excelsior College PBH 321     Page 1 EXPERI MENTAL E.docxExcelsior College PBH 321     Page 1 EXPERI MENTAL E.docx
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docxgitagrimston
 
Sample Size Estimation and Statistical Test Selection
Sample Size Estimation  and Statistical Test SelectionSample Size Estimation  and Statistical Test Selection
Sample Size Estimation and Statistical Test SelectionVaggelis Vergoulas
 
EPA Guidelines for Carcinogen Risk Assessment.pptx
EPA Guidelines for Carcinogen Risk Assessment.pptxEPA Guidelines for Carcinogen Risk Assessment.pptx
EPA Guidelines for Carcinogen Risk Assessment.pptxMegh Vithalkar
 
Case-control study un.uob.pptx
Case-control study un.uob.pptxCase-control study un.uob.pptx
Case-control study un.uob.pptxKifluKumera
 
HEALTHCARE RESEARCH METHODS: Case-Control Studies and Cohort Studies
HEALTHCARE RESEARCH METHODS: Case-Control Studies and Cohort StudiesHEALTHCARE RESEARCH METHODS: Case-Control Studies and Cohort Studies
HEALTHCARE RESEARCH METHODS: Case-Control Studies and Cohort StudiesDr. Khaled OUANES
 
Case control studies
Case control studiesCase control studies
Case control studiesKadium
 
INTRODUCTION TO HEALTHCARE RESEARCH METHODS: Correlational Studies, Case Seri...
INTRODUCTION TO HEALTHCARE RESEARCH METHODS: Correlational Studies, Case Seri...INTRODUCTION TO HEALTHCARE RESEARCH METHODS: Correlational Studies, Case Seri...
INTRODUCTION TO HEALTHCARE RESEARCH METHODS: Correlational Studies, Case Seri...Dr. Khaled OUANES
 
Common statistical pitfalls in basic science research
Common statistical pitfalls in basic science researchCommon statistical pitfalls in basic science research
Common statistical pitfalls in basic science researchRamachandra Barik
 
Causal Inference PowerPoint
Causal Inference PowerPointCausal Inference PowerPoint
Causal Inference PowerPointemphemory
 

Ähnlich wie Hss4303b mortality and morbidity (20)

Research methodology 101
Research methodology 101Research methodology 101
Research methodology 101
 
Lemeshow samplesize
Lemeshow samplesizeLemeshow samplesize
Lemeshow samplesize
 
Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011
 
628362
628362628362
628362
 
Case control surveillance
Case control surveillanceCase control surveillance
Case control surveillance
 
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptxDr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
 
Medpage guide-to-biostatistics
Medpage guide-to-biostatisticsMedpage guide-to-biostatistics
Medpage guide-to-biostatistics
 
Parmetric and non parametric statistical test in clinical trails
Parmetric and non parametric statistical test in clinical trailsParmetric and non parametric statistical test in clinical trails
Parmetric and non parametric statistical test in clinical trails
 
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docx
Excelsior College PBH 321     Page 1 EXPERI MENTAL E.docxExcelsior College PBH 321     Page 1 EXPERI MENTAL E.docx
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docx
 
Sample Size Estimation and Statistical Test Selection
Sample Size Estimation  and Statistical Test SelectionSample Size Estimation  and Statistical Test Selection
Sample Size Estimation and Statistical Test Selection
 
EPA Guidelines for Carcinogen Risk Assessment.pptx
EPA Guidelines for Carcinogen Risk Assessment.pptxEPA Guidelines for Carcinogen Risk Assessment.pptx
EPA Guidelines for Carcinogen Risk Assessment.pptx
 
Case-control study un.uob.pptx
Case-control study un.uob.pptxCase-control study un.uob.pptx
Case-control study un.uob.pptx
 
Research methodology
Research methodologyResearch methodology
Research methodology
 
Research methodology
Research methodologyResearch methodology
Research methodology
 
HEALTHCARE RESEARCH METHODS: Case-Control Studies and Cohort Studies
HEALTHCARE RESEARCH METHODS: Case-Control Studies and Cohort StudiesHEALTHCARE RESEARCH METHODS: Case-Control Studies and Cohort Studies
HEALTHCARE RESEARCH METHODS: Case-Control Studies and Cohort Studies
 
OBSERVATIONAL STUDIES PPT.pptx
OBSERVATIONAL STUDIES PPT.pptxOBSERVATIONAL STUDIES PPT.pptx
OBSERVATIONAL STUDIES PPT.pptx
 
Case control studies
Case control studiesCase control studies
Case control studies
 
INTRODUCTION TO HEALTHCARE RESEARCH METHODS: Correlational Studies, Case Seri...
INTRODUCTION TO HEALTHCARE RESEARCH METHODS: Correlational Studies, Case Seri...INTRODUCTION TO HEALTHCARE RESEARCH METHODS: Correlational Studies, Case Seri...
INTRODUCTION TO HEALTHCARE RESEARCH METHODS: Correlational Studies, Case Seri...
 
Common statistical pitfalls in basic science research
Common statistical pitfalls in basic science researchCommon statistical pitfalls in basic science research
Common statistical pitfalls in basic science research
 
Causal Inference PowerPoint
Causal Inference PowerPointCausal Inference PowerPoint
Causal Inference PowerPoint
 

Mehr von coolboy101pk

Mehr von coolboy101pk (20)

4 -reproductive_system
4  -reproductive_system4  -reproductive_system
4 -reproductive_system
 
Reproductive embryology
Reproductive embryologyReproductive embryology
Reproductive embryology
 
Renalsystem
RenalsystemRenalsystem
Renalsystem
 
Nasal cavity
Nasal cavityNasal cavity
Nasal cavity
 
Legg calve perthes disease donnely 2001 5afad2fc5e0b007027c03a29b821eb3c
Legg calve perthes disease donnely 2001 5afad2fc5e0b007027c03a29b821eb3cLegg calve perthes disease donnely 2001 5afad2fc5e0b007027c03a29b821eb3c
Legg calve perthes disease donnely 2001 5afad2fc5e0b007027c03a29b821eb3c
 
Intestinal obstruction
Intestinal  obstructionIntestinal  obstruction
Intestinal obstruction
 
Diagnosis tx-planning
Diagnosis tx-planningDiagnosis tx-planning
Diagnosis tx-planning
 
Meckels div
Meckels divMeckels div
Meckels div
 
Meckelsdiverticulum
MeckelsdiverticulumMeckelsdiverticulum
Meckelsdiverticulum
 
Surgery cholangitis[1]
Surgery cholangitis[1]Surgery cholangitis[1]
Surgery cholangitis[1]
 
Lung Abscess
Lung AbscessLung Abscess
Lung Abscess
 
Lung abscess
Lung abscessLung abscess
Lung abscess
 
Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology
 
ecg
ecgecg
ecg
 
Ecg 4
Ecg 4Ecg 4
Ecg 4
 
Ecg 7
Ecg 7Ecg 7
Ecg 7
 
Ecg 1
Ecg 1Ecg 1
Ecg 1
 
Ecg 3
Ecg 3Ecg 3
Ecg 3
 
Ecg 5
Ecg 5Ecg 5
Ecg 5
 
Ecg 6
Ecg 6Ecg 6
Ecg 6
 

Kürzlich hochgeladen

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...RKavithamani
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 

Kürzlich hochgeladen (20)

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 

Hss4303b mortality and morbidity

  • 1. HSS4303B – Introduction to Epidemiology Jan 14, 2010 – Measures of Morbidity & Mortality Epidemiologists: “Are they smart and good looking, or good looking and smart?" Discuss.
  • 2.
  • 3.
  • 4. So What Has The Lit Review Revealed?
  • 5.
  • 6.
  • 7.
  • 8. So? Do You Have Enough Info To Inform The Patient?
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.  
  • 16.
  • 17.
  • 18.
  • 19. Meta-analysis of five hypothetical epidemiologic studies (A–E) of the relationship between reduced dietary fat intake and the risk of developing breast cancer.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. Heterogeneity statistics for examples of meta-analyses from the literature. Meta-analyses were conducted using either meta or metan in STATA 15 df=degrees of freedom. Heterogeneity test Topic Outcome/ analysis Effect measure No of studies Q df P I 2 (95% uncertainty interval) * Tamoxifen for breast cancer 16 Mortality Peto odds ratio 55 55.9 54 0.40 3 (0 to 28) Streptokinase after myocardial infarction 17 Mortality Odds ratio 33 39.5 32 0.17 19 (0 to 48) Selective serotonin reuptake inhibitors for depression 13 Drop-out Odds ratio 135 179.9 134 0.005 26 (7 to 40) Magnesium for acute myocardial infarction 18 Death Odds ratio 16 40.2 15 0.0004 63 (30 to 78) Magnetic fields and leukaemia 19 All studies Odds ratio 6 15.9 5 0.007 69 (26 to 87) Amantadine 11 Prevention of influenza Odds ratio 8 12.44 7 0.09 44 (0 to 75)
  • 26. Meta-analyses of six case-control studies relating residential exposure to electromagnetic fields to childhood leukaemia. Summary odds ratio calculated by random effects method Eg.
  • 27. Okay, on to today’s topic...
  • 28. Smoking more than one pack of cigarettes a day increases the risk of cardiovascular disease by 70%-80%, and smoking more than two packs per day increases the risk by 200%. Passive smoke increases the risk by 30%. - Basic Res Cardiol 2000 (Suppl I); 95:152-158 normal rate of miscarriage of pregnancy is 2 to 3%, and amniocentesis increases that risk by an additional 1/2 to 1%. - ds-health.com A 1-month delay in treatment for an early-stage primary breast cancer with a 130-day doubling time increases the risk of axillary lymph node involvement by 0.9% - Obstet Gynecol. 1996 Mar;87(3):414-8.
  • 29. A measure of the occurrence of new cases of the disease of interest in a population The probability of obtaining an outcome, given the presence or change in status of an exposure ?
  • 30.
  • 31. In 1022 cancer patients with fever and granulocytopenia, 530 patients developed clinically or microbiologically documented bacterial infections What is the risk of infection in granulocytopenic febrile cancer patients? 530/1022 = 0.518 = 51.8%
  • 33. A recent study found that 30% of women who date online have had sex on the first date with gentlemen they've met online. Moreover, the study found that 77% of these women had had unprotected sex in those encounters. -w ww.onlinedatingmagazine.com/news2007/womenonlinedatersrisky.html "When you have unprotected sex with people you are meeting online, you are playing russian roullette [sic] with your health. It's not a matter of 'if' you'll get a sexually transmitted disease, but rather 'when' and 'how many'.” -’STI expert’ responding to the results of the study
  • 34.
  • 35. Canada’s STI Surveillance Report: www.phac-aspc.gc.ca The current prevalence is164 cases per 100,000 population, or about 0.16% of the total population, assuming a conservatively estimated base population of 35 million But is the right prevalence statistic to use?
  • 36. The age-specific chlamydia burden among Canadian men aged 25+ is 9374 cases. Canadian adult male population of about 20 million Risk of Canadian male having Chlamydia = 9374/20000000 = 0.00047 = 0.05% Is that the end of the story?
  • 37. Transmission So far we've been talking about the chances of being exposed to an STI. What about actually contracting one? The transmission rate of Chlamydia is between 30% and 40%. In other words, only 30-40% of sexual encounters with an infected person will result in the disease being transmitted. 30% of 0.05% = 0.015% 40% of 0.05% = 0.020%
  • 38. So, assuming the more conservative estimate (0.02% chance of both exposure and transmission), a Canadian woman would have to sleep with 5000 men to get anything resembling the “guarantee” of an STI that the “expert” suggested. What is wrong with this analysis?
  • 39.  
  • 40.  
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.  
  • 47.
  • 48.
  • 49.
  • 53.  
  • 54.
  • 55.
  • 56. Incidence density = A _______ P x T = A cases ______________ P persons x T time = 28 cases ---------------------- 1000 persons x 2 years = 14 cases ---------- person-years
  • 57.
  • 58.
  • 59. Incidence rates Six patients were observed for 8 years. During that time, 2 were diagnosed with dumbass disease How would you go about computing the incidence rate of dumbass disease over this 8 year period? Cumulative incidence or incidence density?
  • 60. Incidence rates Patient Years at risk A B C D E F
  • 61. Incidence rates Patient Years at risk A B C D E F 2 2 3 7 2 6
  • 62. Incidence rates Incidence rate = A / PT A = 2 PT = 2+2+3+7+2+6 = 22 2 / 22 = 0.09 cases / person-year 9 cases / 100 person-years
  • 64.
  • 67. Why is incidence important?
  • 70.
  • 71. But you can also present it as a percent
  • 72. Or… PR = A ----------------- A + B A = number of cases of the disease B = number of people in the population who do not have the disease, but who are at risk for getting it. Therefore A+B = total number of people in the population
  • 73. Example: Obesity in the USA (from CDC.gov)
  • 74.
  • 75.
  • 76. 23% of this class is left handed In 2008, 28% of Americans were clinically obese Point prevalence Period prevalence Interview Question Type of Measure "Do you currently have asthma?" Point prevalence "Have you had asthma during the last (n) years?" Period prevalence "Have you ever had asthma?" Cumulative incidence
  • 77. Consider an old film camera… A single click of the camera produces an image. The total photons on the film, or dots on the image, constitute the point prevalence . If you leave the shutter open for a few seconds, and point the camera to an unmoving object, then many photons accumulate on the film. This is period prevalence . If you use a movie camera and analyze individual frames, then the number of new events in each frame constitute the incidence rate for that frame.
  • 79.
  • 80. Point prevalence for positive x-rays Table 3-7. Hypothetical Example of Chest X-Ray Screening: II. Point Prevalence Screened Population No. with Positive X-Ray Point Prevalence per 1,000 Population 1,000 Hitown 100 100 1,000 Lotown 60 60 Table 3-8. Hypothetical Example of Chest X-Ray Screening: III. Prevalence, Incidence, and Duration Screened Population Point Prevalence per 1,000 Incidence (Occurrences/yr) Duration (yrs) Hitown 100 4 25 Lotown 60 20 3   Prevalence = Incidence × Duration  
  • 82.
  • 83.  
  • 84.
  • 85.
  • 86.
  • 87. The crude death rate , the total number of deaths per year per 1000 people. The crude death rate for the whole world is currently about 8.24 per 1000 per year (according to the current CIA World Factbook.) The perinatal mortality rate , the sum of neonatal deaths and fetal deaths (stillbirths) per 1000 births. (WHO -> 22 weeks pregnancy until 7 days of life) The maternal mortality rate , the number of maternal deaths due to childbearing per 100,000 live births. The infant mortality rate , the number of deaths of children less than 1 year old per 1000 live births. The child mortality rate , the number of deaths of children less than 5 years old per 1000 live births. The standardised mortality rate (SMR)- This represents a proportional comparison to the numbers of deaths that would have been expected if the population had been of a standard composition in terms of age, gender, etc. The age-specific mortality rate (ASMR) - This refers to the total number of deaths per year per 1000 people of a given age (e.g. age 62 last birthday).
  • 88. Infant, neonatal, and postneonatal mortality rates: United States, 1940-2005 (Wikipedia)
  • 89.  
  • 90.  
  • 91.  
  • 93.  
  • 94. Selected leading causes of death, by sex in Canada   1997   Number % Total Males Females     Rate 1 All causes 215,669 100.0 658.7 844.0 521.6 Cancers 58,703 27.2 181.5 229.7 148.5 Diseases of the heart 57,417 26.6 173.0 230.8 129.7 Cerebrovascular diseases 16,051 7.4 47.8 52.8 43.9 Chronic obstructive pulmonary diseases and allied conditions 9,618 4.5 29.0 44.5 20.1 Unintentional injuries 8,626 4.0 27.6 37.8 17.9 Pneumonia and influenza 8,032 3.7 23.7 31.5 19.2 Diabetes mellitus 5,699 2.6 17.4 20.6 14.8 Hereditary and degenerative diseases of the central nervous system 5,049 2.3 15.0 16.7 13.9 Diseases of arteries, arterioles and capillaries 4,767 2.2 14.3 19.5 10.6 Psychoses 4,645 2.2 13.6 13.3 13.4 Suicide 3,681 1.7 12.0 19.5 4.9
  • 95.
  • 96.
  • 97.
  • 98. Example: crude data from the Canadian Injuries Surveillance System: Leading causes of death due to injury, 2004 -passive system based on automatic processing of death certificates and hospital charts
  • 99. Example: Canadian Notifiable Disease Surveillance Report, June 2007 (Ontario is blank because no data was available from Ontario in June/2007) Active system requiring doctors to call the government when certain illness arise
  • 100.
  • 101.
  • 102.
  • 103.